Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP-Reference-Cited by-同舟云学术

Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP

Published:2019-01-31 Issue:2 Volume:20 Page:329-341
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Wigmore Eleanor M.^ORCID,Hafferty Jonathan D.,Hall Lynsey S.,Howard David M.,Clarke Toni-Kim,Fabbri Chiara,Lewis Cathryn M.^ORCID,Uher Rudolf,Navrady Lauren B.,Adams Mark J.^ORCID,Zeng Yanni,Campbell Archie^ORCID,Gibson Jude^ORCID,Thomson Pippa A.^ORCID,Hayward Caroline^ORCID,Smith Blair H.^ORCID,Hocking Lynne J.,Padmanabhan Sandosh,Deary Ian J.,Porteous David J.,Mors Ole,Mattheisen Manuel,Nicodemus Kristin K.^ORCID,McIntosh Andrew M.^ORCID

Funder

Wellcome Trust

Dr. Mortimer and Theresa Sackler Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-019-0067-3.pdf

Reference69 articles.

1. Ustün T, Ayuso-Mateos J, Chatterji S, Mathers C, Murray C. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184:386–92.

2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800.